Jubilant Pharmova Q3 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
1,113.95-27.25 (-2.39%)
Volume16.94 K
Updated: Mon 25 Nov, 2024 | 15:29:39
NSE
1,113-25.50 (-2.24%)
Volume2.28 L
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,094.10
1,160.80
52-Wk: 408.60
1,309.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jubilant Pharmova Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 1,677.101,680.30-%1,552.51-%
    Selling/ General/ Admin Expenses Total 581.50531.80-%567.94-%
    Depreciation/ Amortization 94.6096.60-%94.28-%
    Other Operating Expenses Total 341.70349.40-%360.62-%
    Total Operating Expense 1,553.701,535.10-%1,500.91-%
    Operating Income 123.40145.20-%51.60-%
    Net Income Before Taxes 101.0098.00-%8.73-%
    Net Income 66.8062.50-%-15.67-%
    Diluted Normalized EPS 4.203.94-%-0.98-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts